CBD

Abstract Background: Cannabidiol (CBD) is an approved treatment for childhood epilepsies and a candidate treatment for several other CNS disorders....

Cannabidiol (CBD) is a highly lipophilic compound with poor oral bioavailability, due to poor aqueous solubility and extensive pre-systemic metabolism....

The main active cannabinoids in extracts of Cannabis sativa L., cannabidiolic acid (CBDA) and tetrahydrocannabinolic acid (THCA), are known for their pharmacological...

Abstract Introduction: The development of a novel dosage form for cannabis extract is necessary to improve drug delivery and to...

Δ9-Tetrahydrocannabinol and cannabidiol, which are present in cannabis extract, exhibit low bioavailability when administered orally due to significant first-pass metabolism....

Aim of the Study Due to the physico-chemical properties of cannabidiol (CBD), the vast majority of the marketed products containing...

Abstract Cannabidiol (CBD) has been recognized for its numerous therapeutic benefits, such as neuroprotection, anti-inflammatory effects, and cardioprotection. However, CBD...

Among the various 3D printing techniques, FDM is the most studied in pharmaceutical research. However, it requires the fabrication of...

Introduction: This review aims to provide an overview of the advancements and status of clinical studies and potential permeation-enhancing strategies...

Consumer use of hemp-derived products continues to rise, underscoring the need to establish evidence-based safety guidance. The present study sought...